Efficacy and Safety of LCZ696A in Patients With Essential Hypertension

Mise à jour : Il y a 4 ans
Référence : NCT00549770

Femme et Homme

Extrait

This study was a dose-ranging efficiacy study in patients with essential hypertension to assess the blood pressure lowering effect, and safety of LCZ696 compared to valsartan and placebo. The study will also evaluate the efficacy and safety of AHU377 as compared to placebo.


Critère d'inclusion

  • Hypertension


Liens